1,066
Participants
Start Date
September 2, 2024
Primary Completion Date
December 9, 2024
Study Completion Date
January 6, 2025
Inova Schar Cancer Institute, Fairfax
Virginia Commonwealth University, Richmond
University of Miami, Miami
Regional One Health, Memphis
University of Chicago Medical Center, Chicago
HonorHealth Clinical Research Institute, Scottsdale
St. John's Cancer Institute, Burbank
University of California San Diego, La Jolla
Stanford Gastroenterology and Hepatology, Stanford
Oregon Health Sciences University, Portland
Mount Sinai Hospital, New York
University of Pittsburgh Medical Center, Pittsburgh
The Research Institute of the McGill University Health Centre, Montreal
University of Verona, Verona
Oslo University Hospital, Oslo
Lead Sponsor
Immunovia, Inc.
INDUSTRY